Anthem to pay $16 million settlement for health data breach

Health insurance provider Anthem will pay a record $16 million to HHS Office for Civil Rights (OCR) after a data breach exposed the protected health information of nearly 79 million people.

The record-breaking settlement agreement with the health insurance company was announced by OCR on Monday, Oct. 15. The settlement stems from a security incident that occurred in Jan. 2015, when Anthem discovered hackers gained access to its IT system through an undetected, continuous and targeted cyber attack.

Hackers were able to infiltrate the company’s system through phishing emails sent to an Anthem subsidiary. An investigation of the incident revealed that between Dec. 2014 and Jan. 2015 hackers stole the electronic protected health information of nearly 79 million people. Information stolen included: names, Social Security numbers, medical identification numbers, addresses, dates of birth, email addresses and employment information.

The OCR said Anthem failed to implement appropriate measures for detecting hackers. The office also said the company “failed to conduct an enterprise-wide risk analysis, had insufficient procedures to regularly review information system activity, failed to identify and respond to suspected or known security incidents, and failed to implement adequate minimum access controls to prevent the cyber-attackers from accessing sensitive ePHI, beginning as early as February 18, 2014.”

In addition to the $16 million payment, Anthem will also have to develop a corrective action plan to comply with HIPAA Privacy and Security Rules.

“We know that large healthcare entities are attractive targets for hackers, which is why they are expected to have strong password policies and to monitor and respond to security incidents in a timely fashion or risk enforcement by OCR,” OCR Director Roger Severino said in a statement.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup